Our easy-to-read patient fact sheet compares and contrasts sinus arrhythmia vs AFib (atrial fibrillation) symptoms.

Some asthma therapy appeared to be less effective in Black children living in areas with high levels of nitrogen dioxide (NO2).

Cough is prevalent in patients with progressive pulmonary fibrosis (PPF) and significantly affects their quality of life.

The FDA has expanded the approval of Xenoview (xenon Xe 129 hyperpolarized) to include use in pediatric patients aged 6 years and older.

Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for nasal congestion relief.